Silintan Capsules Recalled for Undeclared Meloxicam
This recall was posted 2 months ago. Check the FDA source for the latest status.
Class I Recall — Most Serious
This is a Class I recall — the most serious type. Products covered by this recall may cause serious health consequences or death.
Anthony Trinh, 123Herbals LLC has announced a nationwide recall of Silintan capsules due to the presence of undeclared meloxicam. This recall affects all lots of the product, which is marketed as a dietary supplement for joint and body ache relief.
Products Affected:
- Silintan capsules packaged in 25-count plastic bottles with blue labels.
- All lot numbers within expiry are included in this recall.
- Distributed nationwide online at 123herbals.com.
Reason for Recall:
FDA analysis found that Silintan capsules contain meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) approved for managing osteoarthritis pain. Meloxicam is not approved for use in dietary supplements, making Silintan an unapproved new drug.
Health Risks:
Exposure to meloxicam above the recommended daily dose of 15mg can lead to serious health risks, including blood clots, heart attack, stroke, hypersensitivity reactions, gastrointestinal bleeding, and acute kidney injury. These risks are especially significant for elderly patients and those taking blood thinners or other NSAIDs.
Consumer Action:
- Stop using Silintan capsules immediately.
- Return the product to the place of purchase for a refund or discard it.
- Contact Anthony Trinh, 123Herbals LLC at [email protected] or call 1-626-656-3202 for more information.
- Consult a healthcare provider if you experience any adverse effects.
To date, no adverse events have been reported related to this recall. Consumers can report any adverse reactions to the FDA's MedWatch Adverse Event Reporting program online or by mail.
Where Products Were Sold
This recall affects products distributed nationwide across the United States.